Education
About Us
Working with TipRanks
Follow Us
Balaxi Pharmaceuticals Limited (IN:BALAXI)
:BALAXI
BALAXI Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹44.41 - ₹127.45
Previous CloseN/A
Volume27.88K
Average Volume (3M)390.24K
Market Cap
₹526.13M
Enterprise Value₹5.61B
Total Cash (Recent Filing)₹608.67M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)12.6
Beta0.85
Next Earnings
Oct 31, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 01, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding11,041,500
10 Day Avg. Volume239,150
30 Day Avg. Volume390,238
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Balaxi Pharmaceuticals Limited News
BALAXI FAQ
What was Balaxi Pharmaceuticals Limited’s price range in the past 12 months?
Balaxi Pharmaceuticals Limited lowest stock price was ₹44.41 and its highest was ₹127.45 in the past 12 months.
What is Balaxi Pharmaceuticals Limited’s market cap?
Balaxi Pharmaceuticals Limited’s market cap is ₹526.13M.
When is Balaxi Pharmaceuticals Limited’s upcoming earnings report date?
Balaxi Pharmaceuticals Limited’s upcoming earnings report date is Oct 31, 2025 which is in 83 days.
How were Balaxi Pharmaceuticals Limited’s earnings last quarter?
Balaxi Pharmaceuticals Limited released its earnings results on Aug 05, 2025. The company reported ₹0.263 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.263.
Is Balaxi Pharmaceuticals Limited overvalued?
According to Wall Street analysts Balaxi Pharmaceuticals Limited’s price is currently Overvalued.
Does Balaxi Pharmaceuticals Limited pay dividends?
Balaxi Pharmaceuticals Limited pays a Notavailable dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Balaxi Pharmaceuticals Limited dividends here
What is Balaxi Pharmaceuticals Limited’s EPS estimate?
Balaxi Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Balaxi Pharmaceuticals Limited have?
Balaxi Pharmaceuticals Limited has 11,041,500 shares outstanding.
What happened to Balaxi Pharmaceuticals Limited’s price movement after its last earnings report?
Balaxi Pharmaceuticals Limited reported an EPS of ₹0.263 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.027%.
Which hedge fund is a major shareholder of Balaxi Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:BALAXI
Company Description
Balaxi Pharmaceuticals Limited
Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.
Technical Analysis
Biofil Chemicals & Pharmaceuticals Ltd.
―
Ind-Swift Ltd.
―
Lasa Supergenerics Ltd.
―
Vivimed Labs Limited
―